SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy

A woman in her 40s presented to the emergency department with headache and unintentional weight loss in September 2018. Investigations revealed a widely metastatic pan-negative melanoma of unknown primary. She had multiple lines of treatment including combination immunotherapy and chemotherapy. Next...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Sonya Minmin, Lucas, Mairi, Brady, Michelle, Kelly, Catherine Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230919/
https://www.ncbi.nlm.nih.gov/pubmed/34167970
http://dx.doi.org/10.1136/bcr-2020-238494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230919/
https://www.ncbi.nlm.nih.gov/pubmed/34167970
http://dx.doi.org/10.1136/bcr-2020-238494

Ejemplares similares